Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

SCA shares hit record high on report of $22 billion bid

04/13/2017 | 09:05am EDT
A woman walks past an advertisement of a tissue paper brand of Swedish SCA company on a street in Santiago

STOCKHOLM (Reuters) - Shares of Sweden's SCA (>> Svenska Cellulosa SCA AB) touched a record high on Thursday on a media report that a group of private equity firms had bid 200 billion crowns (17.85 billion pounds) for its hygiene products arm, a top global producer of diapers and toilet paper.

STOCKHOLM (Reuters) - Shares of Sweden's SCA (>> Svenska Cellulosa SCA AB) touched a record high on Thursday on a media report that a group of private equity firms had bid 200 billion crowns (17.85 billion pounds) for its hygiene products arm, a top global producer of diapers and toilet paper.

Swedish daily Dagens Nyheter, citing unnamed sources, said at least two international private equity firms had jointly bid for the hygiene business a few weeks ago. It did not name the bidders.

Last week SCA formally approved a proposal to spin off its hygiene products business, to be called Essity, as a separately listed unit, leaving the forestry business under the SCA name.

SCA, the world's largest maker of incontinence pads and the second largest in consumer tissues such as napkins and toilet paper, declined to comment on the bid report.

The hygiene business accounts for the bulk of SCA's value.

The report did not say whether the 200 billion crown figure represents the suitors' basic valuation or total enterprise value, which also includes debt.

Private equity buyers often cite enterprise value when discussing bids.

Handelsbanken Capital Markets analyst Karri Rinta said a 200 billion crown price tag for the business would represent a good price for SCA but would be "pretty uninteresting" to shareholders if it referred to enterprise value.

Analysts at investment bank UBS and Handelsbanken Capital Markets estimate the hygiene operation's worth at between 193 billion crowns and 213 billion crowns.

The business had 31 billion crowns of long-term debt as the end of 2016, according to a statement this week.


SCA shares jumped as much as 9.8 percent to a record high early on Thursday before closing the shortened trading day with a gain of 7.8 percent, the top performer in the STOXX Europe 600 index. <.STOXX>

SCA has said it aims to list Essity as soon as possible and no later than the second half of 2017.

Investor interest in SCA has increased since it announced the spin-off plan last August, with several media reports of planned bids for its forestry arm.

Essity counts U.S. companies Procter & Gamble (>> Procter & Gamble Co) and Kimberly-Clark (>> Kimberly Clark Corp) among its main rivals.

Its leading brands include Plenty kitchen roll, Libero baby diapers and Tena incontinence care products, with diaper sales growing in emerging markets and incontinence pads increasingly in demand among ageing populations in wealthy nations.

Roger Bostrom, a union representative on the SCA board, said he was unaware of any bid. "I have not seen anything, heard anything, and I have no comment," he told Reuters.

A banking source said he did not expect one of Essity's rivals to make a bid, adding that Procter & Gamble would face antitrust problems and that Kimberly-Clark had already exited parts of its European business some years ago.

Essity, with sales of 101 billion crowns last year, accounts for 86 percent of total group sales. The division made an adjusted operating profit of 11.8 billion crowns.

The SCA group had an overall market value of 194 billion crowns at Wednesday's market close.

SCA agreed in December to buy German bandage and plaster cast maker BSN Medical for 2.74 billion euros. The new acquisition form parts of Essity's business.

(Additional reporting by Anna Ringstrom and Bjorn Rundstrom in Stockholm and Martinne Geller in London; Editing by Mark Bendeich, Jason Neely and David Goodman)

By Johannes Hellstrom

© Reuters 2017
Stocks mentioned in the article
ChangeLast1st jan.
ESSITY AKTIEBOLAG 4.73% 283.3 Delayed Quote.2.27%
JASON CO., LTD. -1.52% 519 End-of-day quote.-22.31%
KIMBERLY-CLARK CORPORATION 1.34% 133.04 Delayed Quote.-2.37%
PROCTER & GAMBLE COMPANY 1.08% 140.83 Delayed Quote.0.14%
SVENSKA CELLULOSA AKTIEBOLAGET SCA 1.87% 138.85 Delayed Quote.-4.88%
10:00aKIMBERLY CLARK : Personal Care Unit Likely to Lead Q3 Gains; Outlook May be Cautious, RBC ..
10/14KIMBERLY CLARK : New Mississippi Initiative Will Combat Leading Cause of Involuntary Land ..
10/11KIMBERLY CLARK : Announces Schedule for Third Quarter 2021 Financial Results
10/11KIMBERLY CLARK : Plan International, Kimberly-Clark And Its Kotex Brand Announce Expanded ..
10/11Plan International, Kimberly-Clark and Its Kotex Brand Announce Expanded Partnership fo..
10/04PLAINS ALL AMERICAN PIPELINE L P : Analysis-Diverse boards to pick the next Boston and Dal..
09/28JAMIE DIMON : Exclusive-JPMorgan's Dimon cautions a U.S. default would be 'potentially cat..
09/27KIMBERLY CLARK : National Diaper Need Awareness Week Aims to Spread Awareness and Educatio..
09/23Explainer-Whether centrist or progressive, the Fed's new regulatory chief has long to-d..
09/15KIMBERLY CLARK CORP : Financial Statements and Exhibits (form 8-K)
More news
Analyst Recommendations on KIMBERLY-CLARK CORPORATION
More recommendations
Financials (USD)
Sales 2021 19 417 M - -
Net income 2021 2 094 M - -
Net Debt 2021 8 216 M - -
P/E ratio 2021 21,5x
Yield 2021 3,39%
Capitalization 44 803 M 44 803 M -
EV / Sales 2021 2,73x
EV / Sales 2022 2,64x
Nbr of Employees 46 000
Free-Float 88,9%
Duration : Period :
Kimberly-Clark Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends KIMBERLY-CLARK CORPORATION
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus HOLD
Number of Analysts 19
Last Close Price 133,04 $
Average target price 137,67 $
Spread / Average Target 3,48%
EPS Revisions
Managers and Directors
Michael D. Hsu Chairman & Chief Executive Officer
Maria G. Henry Chief Financial Officer & Senior Vice President
Robert Long Chief Research & Development Officer
Manoj Kumbhat Global Chief Investment Officer
Robert William Decherd Independent Director